operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full

Page 121

Incidents 37.1 Incident management The site team should be trained and prepared to respond to three possible medical emergencies associated with COVID-19 vaccination: fainting, hyperventilation, and anaphylaxis. The appropriate medication and equipment must be on site to manage these incidents. Refer to section 2.3 of the Immunisation Handbook for guidance on emergency equipment required to manage post-vaccination medical emergencies. Adverse events should be managed in accordance with HQSC Guide to the National Adverse Events Reporting Policy 2017. In the event of a serious adverse event or incident it is important to follow organisational process to report, review, and learn from the incident. •

Appendix I outlines the process steps for notifying serious incidents to the programme. This includes the COVID-19 Vaccine related severity assessment codes (SAC) and the form required to notify the programme of incident and serious adverse events.

37.2 Adverse events during observation period If any consumer has an adverse event during the 15-minute observation period at the vaccination site, appropriate medical attention must be provided. The on-site adverse event must be recorded and submitted in the CIR to support reporting on adverse events following COVID-19 vaccine immunisation. For more information regarding managing medical emergencies and anaphylaxis, please see section 2.3 of the Immunisation Handbook.

37.3 Recording an anaphylaxis event Where a suspected anaphylaxis event occurs following a vaccination event, it is important to record and submit consumer details of the event in the CIR. The person who handled the event must complete the anaphylaxis checklist record (found on the IMAC website) as soon as practical. The anaphylaxis checklist should be completed and uploaded via the Dropbox to the CARM link. Adverse events should be notified to the site lead clinician, who can undertake a clinical review and determine appropriate actions with the site manager (such as pausing vaccinations for a time, should this be required).

Version 33.0 Page 121


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Document version control

2min
pages 155-156

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 153-154

Appendix J: Risk mitigations for vaccination sites

2min
page 152

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 140-141

Appendix D: Logistics and inventory management

1min
page 139

Appendix G: Vaccination site screening questions

1min
page 143

Variations

1min
page 126

Incidents

6min
pages 121-125

National Immunisation Booking System

11min
pages 115-120

Affected persons under the Vaccinations Order

4min
pages 112-114

COVID-19 Trial Vaccinations

1min
page 111

Home vaccinations

2min
pages 109-110

Mobile vaccination team

1min
page 108

Vaccination in Hospital

1min
page 107

Vaccination and Surveillance Testing

1min
page 106

Vaccination in high-risk or screened ‘positive’ consumers

4min
pages 102-104

Third primary dose for severely immunocompromised

1min
page 105

Section E: Additional programme guidance, variations and incidents

1min
page 101

AstraZeneca Vaccine administration and observation

7min
pages 95-100

AstraZeneca Preparation of doses

2min
pages 93-94

AstraZeneca Operational phase

1min
page 92

Booking and scheduling

1min
page 91

Section D: AstraZeneca COVID-19 Vaccine

1min
page 90

Paediatric Pfizer Vaccine administration and observation

8min
pages 85-89

Paediatric Pfizer Preparation of doses

3min
pages 82-84

Pfizer Vaccine administration and observation

12min
pages 69-77

Pfizer Preparation of doses

4min
pages 66-68

Pfizer Operational phase

2min
pages 63-64

Protecting security and privacy

1min
page 62

Vaccinating consumers aged 12 to 15 years

1min
page 65

Booking and scheduling

2min
pages 60-61

Becoming a COVID-19 Vaccination site

1min
page 58

Site readiness and closure

1min
page 57

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 55-56

COVID-19 Immunisation Register

3min
pages 27-29

Logistics

1min
page 30

Vaccine storage and handling

7min
pages 37-42

Infection prevention and control (IPC

2min
pages 25-26

Preparing the vaccination workforce

7min
pages 20-24

Equipment ordering and demand planning

7min
pages 31-36

Site considerations

7min
pages 16-19

Section A: Ready to vaccinate

1min
page 13
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full by WBOP PHO - Issuu